rubschisandrin has been researched along with verapamil in 1 studies
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
Studies (rubschisandrin) | Trials (rubschisandrin) | Recent Studies (post-2010) (rubschisandrin) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
5 | 0 | 2 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adámková, L; Carnecká, M; Humpa, O; Páchniková, G; Porubová Koubíková, L; Slanina, J; Slaninová, I; Smejkal, K | 1 |
1 other study(ies) available for rubschisandrin and verapamil
Article | Year |
---|---|
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cyclooctanes; Doxorubicin; G2 Phase Cell Cycle Checkpoints; Humans; Lignans; Molecular Structure; Polycyclic Compounds; Quantitative Structure-Activity Relationship; Russia; Schisandra; Seeds | 2014 |